|Study Description:||The goal of this clinical research study is to learn if bevacizumab, when given |
in combination with 2 cycles of high-dose chemotherapy, can help to control
germ-cell tumors. The first cycle of chemotherapy will include the drugs
gemcitabine, docetaxel, melphalan, and carboplatin. The second cycle of
chemotherapy will include the drugs ifosfamide, carboplatin, and etoposide. The
safety of these drug combinations will also be studied.